CytoReason expands deal with Sanofi to look at IBD
CytoReason, which creates computational disease modeling, has announced an expansion of its collaboration with Sanofi.…
January 24, 2023 - 2 minutes
News and Trends
Beyond Biotech podcast 30: Advanced Therapies Congress, BioAlps, Bionter, C2i Genomics
The guests on our podcast this week are: Jessica Robinson, project director, Advanced Therapies Congress,…
January 20, 2023 - 3 minutes
Aldevron launches type-V CRISPR Nuclease
Aldevron, which develops and manufactures plasmid DNA, RNA and proteins for the biotech industry, has…
January 20, 2023 - 2 minutes
The magical microbiome
By Brittany Niccum and Han Wei Now that we are past the holiday season and…
January 20, 2023 - 6 minutes
New drug could replace current standard for treating brain cancer
Glioblastoma (GBM) is a WHO grade IV brain tumor with dismal prognosis. Although post-surgical radiation…
January 20, 2023 - 3 minutes
DeuterOncology closes financing round to start lung cancer study
DeuterOncology, a clinical-stage drug development company, has closed €5.65 million ($6.1 million) series A financing,…
January 20, 2023 - 2 minutes
Brenus Pharma and InSphero bag €1.5M for next-generation cancer cell immunotherapy
Brenus Pharma and InSphero AG have received a €1.5 million grant for the collaborative project…
January 20, 2023 - 4 minutes
Netherlands Cancer Institute to use Proscia platform
Proscia, a provider of digital and computational pathology solutions, has announced that the Netherlands Cancer…
January 19, 2023 - 2 minutes
Cloned maggot enzyme wound treatment moves closer to reality
Cambridge U.K. biotech company SolasCure, which is developing a wound cleaning technology, has published its…
January 19, 2023 - 2 minutes
Avacta completes fourth dose escalation in tumor study
Avacta Group plc says that AVA6000 continues to show a favorable safety profile in the…
January 19, 2023 - 3 minutes
GPCR Therapeutics launches multiple myeloma trial
GPCR Therapeutics, Inc., a drug discovery company targeting G Protein Coupled Receptors (GPCR) pairs, has…
January 19, 2023 - 2 minutes
Pathalys Pharma brings in $150M for SHPT trials
Pathalys Pharma, Inc. and Launch Therapeutics (Launch Tx) have announced a collaboration to advance phase…
January 19, 2023 - 3 minutes
